HEALTH● LOWOct 2 · Oct 2, 2026, 4:08 PM
Pfizer says phase 3 data buoys Litfulo as a vitiligo treatment
Seeking Alpha Tech · global
Pfizer announced that positive Phase 3 trial data supports Litfulo's effectiveness as a treatment for vitiligo. This represents a development in medical research for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH10m agoFG releases ₦40.7 billion for primary healthcare, expands coverage to 13,000 facilitiesPremium TimesHEALTH17m agoAmericans with disabilities worried over plan to slash national health surveyThe Independent WorldHEALTH28m agoWATCH: Measles, GLP-1s and anti-aging: How to protect your healthABC NewsHEALTH37m agoKenya Announces Second Ebola Case, Says ‘No Evidence’ Of Wider SpreadChannels TV